Vantage Medicines Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -24.56%
- Profit Growth 193.65%
- Ebitda 124.30%
- Net Worth 0.72%
- Total Assets -0.07%
About Vantage Medicines
Vantage Medicines Limited (VML) is a Public Limited Indian Non-Government Company incorporated in India on 26 February 2010 and has a history of 14 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Umesh Sapra, Hemant Shahpuri, and Nitin Gulati serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100DL2010PLC199565
-
Company No.
199565
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
26 Feb 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Vantage Medicines?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Sapra
|
Director | 26-Feb-2010 | Current |
|
Hemant Shahpuri
|
Director | 26-Feb-2010 | Current |
|
Nitin Gulati
|
Additional Director | 12-May-2011 | Current |
Financial Performance of Vantage Medicines.
Vantage Medicines Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 24.56% decrease. The company also saw a substantial improvement in profitability, with a 193.65% increase in profit. The company's net worth moved up by a moderate rise of 0.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vantage Medicines?
In 2017, Vantage Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Geeignet Technologies Private LimitedUmesh Sapra is a mutual person
-
Akhet Pharmaceuticals Private LimitedNitin Gulati is a mutual person
-
Bevy Estate Services Private LimitedHemant Shahpuri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vantage Medicines?
Unlock and access historical data on people associated with Vantage Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vantage Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vantage Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
